Adaptive Biotechnologies Corporation (ADPT)

NASDAQ: ADPT · Real-Time Price · USD

24.18

+1.62 (7.18%)

At close: Jul 30, 2026, 4:00 PM EDT

24.31

+0.13 (0.54%)

After-hours: Jul 30, 2026, 5:01 PM EDT

Adaptive Biotechnologies Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	308.08	276.98	178.96	170.28	185.31	154.34
Revenue Growth	50.13%	54.77%	5.10%	-8.11%	20.06%	56.88%
Gross Profit	232.83	205.62	106.88	94.72	127.4	105.04
Operating Income	-37.46	-57.12	-162.55	-227.04	-200.19	-208.97
Net Income	-63.85	-59.5	-159.49	-225.25	-200.19	-207.28
Earnings Per Share	-0.41	-0.39	-1.08	-1.56	-1.40	-1.48
EPS Growth	-	-	-	-	-	-

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Minimal Residual Disease (MRD)	212.33	145.53	102.74	87.14
Immune Medicine	64.64	33.43	67.54	98.16
Total	276.98	178.96	170.28	185.31

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	344.26	226.98	222.29	346.4	498.2	353.06
Total Debt	410.5	79.15	89.39	98.77	108	111.74
Net Cash (Debt)	-66.24	147.83	132.91	247.63	390.19	241.32
Net Cash Growth	-	11.23%	-46.33%	-36.54%	61.69%	-58.42%
Net Cash Per Share	-0.42	0.97	0.90	1.72	2.74	1.72

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-27.04	-45.99	-95.21	-156.32	-183.95	-192.73
Capital Expenditures	-2.5	-2.96	-3.66	-10.7	-16.35	-61.75
Free Cash Flow	-29.54	-48.95	-98.88	-167.02	-200.29	-254.47
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	75.57%	74.24%	59.72%	55.63%	68.75%	68.06%
Operating Margin	-12.16%	-20.62%	-90.83%	-133.33%	-108.03%	-135.39%
Pretax Margin	-13.07%	-21.47%	-89.18%	-132.32%	-108.13%	-134.31%
Profit Margin	-20.77%	-21.47%	-89.18%	-132.32%	-108.13%	-134.31%
FCF Margin	0.00%	-17.67%	-55.25%	-98.09%	-108.09%	-164.87%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	11.86	9.02	4.95	4.18	5.90	25.71